A recent intriguing example is a study that identified a new class of immunosuppressive CD4 + T cells in sarcoma-bearing mice that are distinct from Treg, express a distinct set of cell-surface and intracellular genes, and are differentially induced by vaccination with high dose versus low dose MHC-II tumor antigens (Sultan et al, 2024). This evidence concerns the gene CD4 and neoplasm.